MELPHALAN Side Effects

6968125-4 | Bacterial Infection
on Aug 24, 2010 Female patient from ITALY , 70 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?). Melphalan dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), FOTEMUSTINE (View Fotemustine Review and Fotemustine Label ), ARA C (View Ara-c Review and Ara-c Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

6968124-2 | Meningitis Bacterial
Patient was taking Melphalan (View Usage). Patient had the following side effects: meningitis bacterial on Aug 24, 2010 from ITALY Additional patient health information: Female patient , 52 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Melphalan dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), FOTEMUSTINE (View Fotemustine Review and Fotemustine Label ), ARA C (View Ara-c Review and Ara-c Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

6968121-7 | Asthenia, Clostridium Test Positive, Dehydration, Hypotension, Renal Failure Acute
Adverse event was reported on Aug 31, 2010 by a Male patient taking Melphalan (View Usage) (Dosage: 16mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 79 years of age, weighting 180.3 lb, After Melphalan was administered, patient had the following side effects: asthenia, clostridium test positive, dehydration, hypotension, renal failure acute. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), VELCADE (2mg Weekly) (View Velcade Review and Velcade Label ). Patient was hospitalized.

6963429-3 | Diarrhoea, Pancytopenia, Renal Failure
on Aug 25, 2010 Male patient from ITALY , weighting 158.7 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, thrombosis prophylaxis, anxiety (What is anxiety?), antiviral prophylaxis and was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, pancytopenia, renal failure. Melphalan dosage: .2mgk Per Day. During the same period patient was treated with THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (2mgk Per Day) (View Prednisone Review and Prednisone Label ), LASIX (25mg Per Day) (View Lasix Review and Lasix Label ), ZYLORIC (150mg Per Day) (View Zyloric Review and Zyloric Label ), LOW MOLECULAR WEIGHT HEPARIN (View Low Molecular Weight Heparin Review and Low Molecular Weight Heparin Label ), LANSOPRAZOLE (30mg Per Day) (View Lansoprazole Review and Lansoprazole Label ), LEXOTAN (10drop Per Day) (View Lexotan Review and Lexotan Label ), ZELITREX (1g Per Day) (View Zelitrex Review and Zelitrex Label ). Patient was hospitalized and became disabled.


6930519-0 | Diarrhoea, Hypotension, Infection, Pyrexia
on Aug 16, 2010 Female patient from UNITED STATES , 62 years of age, weighting 110.2 lb, was diagnosed with amyloidosis and was treated with Melphalan (View Usage). Patient had the following side effects: diarrhoea, hypotension, infection (What is infection?), pyrexia. Melphalan dosage: 70mgm2 Per Day. During the same period patient was treated with EMOLLIENTS (View Emollients Review and Emollients Label ), PROTONIX (View Protonix Review and Protonix Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), MAGNESIUM SULFATE (View Magnesium Sulfate Review and Magnesium Sulfate Label ). Patient was hospitalized.

6928710-2 | Decreased Appetite, Fatigue, Febrile Neutropenia, Hypoxia, Pyrexia, Respiratory Tract Infection
Patient was taking Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: decreased appetite, fatigue, febrile neutropenia, hypoxia, pyrexia, respiratory tract infection on Aug 06, 2010 from GREECE Additional patient health information: Female patient , weighting 88.18 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Melphalan dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6919889-7 | Fatigue, Feeling Abnormal, Pancytopenia, Platelet Count Decreased, Rash, White Blood Cell Count Decreased
Adverse event was reported on Jul 21, 2010 by a Male patient taking Melphalan (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 80 years of age, Patient experienced the following unwanted or unexpected effects: fatigue, feeling abnormal, pancytopenia, platelet count decreased, rash (What is rash?), white blood cell count decreased. During the same period patient was treated with THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NAMENDA (View Namenda Review and Namenda Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).

6919471-1 | Dyspnoea, Infection, Pyrexia
on Aug 09, 2010 Male patient from BELGIUM , weighting 121.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), thrombosis prophylaxis and was treated with Melphalan (View Usage). Patient had the following side effects: dyspnoea, infection (What is infection?), pyrexia. Melphalan dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6908767-5 | Myelodysplastic Syndrome
on Jul 30, 2010 Female patient from UNITED STATES , 57 years of age, weighting 198.9 lb, was diagnosed with mantle cell lymphoma and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: myelodysplastic syndrome. Melphalan dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), RITUXAN (View Rituxan Review and Rituxan Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ).

6906357-1 | Body Temperature Increased, Chills, Erythema, Graft Versus Host Disease, Infection
Patient was taking Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, chills, erythema, graft versus host disease, infection (What is infection?) on Jul 26, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 110.2 lb, was diagnosed with amyloidosis and. Melphalan dosage: 70mgm2 Per Day. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), PREVACID (View Prevacid Review and Prevacid Label ), CITRACAL + D (View Citracal + D Review and Citracal + D Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6871768-X | Accident, Eye Injury, Face Injury, Neutropenia, Surgery, White Blood Cell Count Decreased
Adverse event was reported on Jul 14, 2010 by a Male patient taking Melphalan (View Usage) (Dosage: 6mg Cyclic) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: accident, eye injury, face injury, neutropenia, surgery (What is surgery?), white blood cell count decreased. During the same period patient was treated with REVLIMID (10mg Cyclic) (View Revlimid Review and Revlimid Label ).

6541171-0 | Presyncope
on Jan 15, 2010 Female patient from UNITED STATES , 63 years of age, weighting 123.5 lb, was diagnosed with amyloidosis and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: presyncope. Melphalan dosage: 50mgm2 Per Day. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIURETICS (View Diuretics Review and Diuretics Label ).

6501559-0 | Pyrexia
on Dec 02, 2009 Male patient from GERMANY , weighting 220.5 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), polyarthritis and was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia. Melphalan dosage: 30mg Per Day. During the same period patient was treated with DECORTIN (100mg Per Day) (View Decortin Review and Decortin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6501505-X | Abdominal Distension, Discomfort, Febrile Neutropenia, Ileus
Patient was taking Melphalan (View Usage). Patient had the following side effects: abdominal distension, discomfort, febrile neutropenia, ileus on Dec 11, 2009 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 199.7 lb, was diagnosed with non-hodgkin's lymphoma and. Melphalan dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), NEXIUM (View Nexium Review and Nexium Label ), POTASSIUM (View Potassium Review and Potassium Label ). Patient was hospitalized.

6498261-0 | Bone Marrow Failure, Gastrointestinal Disorder, Parotitis
Adverse event was reported on Dec 03, 2009 by a Female patient taking Melphalan (View Usage) (Dosage: 50mg Per Day) . Location: JAPAN , child 8 years of age, After Melphalan was administered, patient had the following side effects: bone marrow failure, gastrointestinal disorder, parotitis. During the same period patient was treated with THIOTEPA (View Thiotepa Review and Thiotepa Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ).

6481346-2 | Fanconi Syndrome, Glucose Urine Present, Interstitial Lung Disease, Protein Urine
on Nov 24, 2009 Female patient from JAPAN , child 2 years of age, was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: fanconi syndrome, glucose urine present, interstitial lung disease, protein urine. Melphalan dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), IRRADIATION (View Irradiation Review and Irradiation Label ), BUSULPHAN (View Busulphan Review and Busulphan Label ), L PHENYLALANINE (View L-phenylalanine Review and L-phenylalanine Label ).

6477989-2 | Cardiac Failure, Cardiovascular Insufficiency
on Nov 26, 2009 Male patient from POLAND , 53 years of age, was treated with Melphalan (View Usage). Patient had the following side effects: cardiac failure, cardiovascular insufficiency. Melphalan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), LOMUSTINE (View Lomustine Review and Lomustine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6474734-1 | Bone Marrow Failure, Parotitis
Patient was taking Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: bone marrow failure, parotitis on Nov 24, 2009 from JAPAN Additional patient health information: Female patient , child 8 years of age, . Melphalan dosage: .

6470702-4 | Cough, Infection, Productive Cough
Adverse event was reported on Nov 30, 2009 by a Male patient taking Melphalan (View Usage) (Dosage: ) was diagnosed with amyloidosis and. Location: UNITED STATES , 57 years of age, weighting 158.7 lb, Patient experienced the following unwanted or unexpected effects: cough, infection (What is infection?), productive cough. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ). Patient was hospitalized.

6464850-2 | Deep Vein Thrombosis, Dizziness, Haemodialysis, Infection, Oedema Peripheral, Renal Failure Acute, Renal Pain, Ultrasound Scan
on Jul 31, 2009 Male patient from UNITED STATES , 79 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), deep vein thrombosis (What is deep vein thrombosis?) and was treated with Melphalan (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), haemodialysis, infection (What is infection?), oedema peripheral, renal failure acute, renal pain, ultrasound scan. Melphalan dosage: . During the same period patient was treated with REVLIMID (5mg Per Day) (View Revlimid Review and Revlimid Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PLAVIX (View Plavix Review and Plavix Label ), DIOVAN (View Diovan Review and Diovan Label ), PROTONIX (View Protonix Review and Protonix Label ), RESTORIL (View Restoril Review and Restoril Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ). Patient was hospitalized.

6457058-8 | Lobar Pneumonia, Traumatic Lung Injury, White Blood Cell Count Decreased
on Oct 16, 2009 Female patient from UNITED STATES , 83 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: lobar pneumonia, traumatic lung injury, white blood cell count decreased. Melphalan dosage: . During the same period patient was treated with REVLIMID (10mg Per Day) (View Revlimid Review and Revlimid Label ), NOVOLOG (View Novolog Review and Novolog Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.

6454086-3 | Cardiac Failure, Cardiovascular Insufficiency
Patient was taking Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, cardiovascular insufficiency on Nov 16, 2009 from POLAND Additional patient health information: Female patient , 53 years of age, . Melphalan dosage: .

6444767-X | Fatigue, Infection
Adverse event was reported on Nov 12, 2009 by a Female patient taking Melphalan (View Usage) (Dosage: .1mgk Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?), bone pain and. Location: FRANCE , weighting 99.21 lb, Patient had the following side effects: fatigue, infection (What is infection?). During the same period patient was treated with PREDNISONE (2mgk Per Day) (View Prednisone Review and Prednisone Label ), THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), KARDEGIC (160mg Per Day) (View Kardegic Review and Kardegic Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), DOLIPRANE (4g Four Times Per Day) (View Doliprane Review and Doliprane Label ), BLOOD CELLS (View Blood Cells Review and Blood Cells Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

6441496-3 | Fatigue, Infection
on Nov 06, 2009 Female patient from FRANCE , weighting 99.21 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), bone pain and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: fatigue, infection (What is infection?). Melphalan dosage: .1mgk Per Day. During the same period patient was treated with PREDNISONE (2mgk Per Day) (View Prednisone Review and Prednisone Label ), THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), KARDEGIC (160mg Per Day) (View Kardegic Review and Kardegic Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), DOLIPRANE (4g Four Times Per Day) (View Doliprane Review and Doliprane Label ), BLOOD CELLS (View Blood Cells Review and Blood Cells Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

6430680-0 | Alanine Aminotransferase Increased, Blood Bilirubin Increased, Fibrosis, Hepatitis B, Hepatitis B Dna Increased, Inflammation
on Oct 27, 2009 Male patient from BELGIUM , 67 years of age, was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood bilirubin increased, fibrosis, hepatitis b (What is hepatitis b?), hepatitis b dna increased, inflammation. Melphalan dosage: . During the same period patient was treated with LAMIVUDINE (100mg Per Day) (View Lamivudine Review and Lamivudine Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

6430622-8 | Cerebral Ischaemia, Cranial Nerve Disorder, Facial Palsy
Patient was taking Melphalan (View Usage). Patient had the following side effects: cerebral ischaemia, cranial nerve disorder, facial palsy on Nov 04, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, weighting 158.7 lb, was diagnosed with amyloidosis and. Melphalan dosage: .

6428443-5 | Febrile Neutropenia, Hypoxia
Adverse event was reported on Oct 30, 2009 by a Male patient taking Melphalan (View Usage) (Dosage: ) was diagnosed with mantle cell lymphoma and. Location: UNITED STATES , 43 years of age, After Melphalan was administered, patient had the following side effects: febrile neutropenia, hypoxia. During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), CARMUSTINE (View Carmustine Review and Carmustine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), ARA C (View Ara-c Review and Ara-c Label ), RITUXAN (View Rituxan Review and Rituxan Label ), MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), CLARITIN (View Claritin Review and Claritin Label ). Patient was hospitalized.

6426308-6 | Nausea
on Nov 03, 2009 Male patient from UNITED STATES , 59 years of age, was diagnosed with neoplasm malignant and was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). Melphalan dosage: 9 Tab Every Day Po. Patient was hospitalized.

6417928-3 | Fatigue, Infection
on Oct 22, 2009 Female patient from UNITED STATES , 86 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), venous thrombosis, bone pain and was treated with Melphalan (View Usage). Patient had the following side effects: fatigue, infection (What is infection?). Melphalan dosage: .1mgk Per Day. During the same period patient was treated with PREDNISONE TAB (2mgk Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), THALIDOMIDE (100mg Per Day) (View Thalidomide Review and Thalidomide Label ), KARDEGIC (160mg Per Day) (View Kardegic Review and Kardegic Label ), CARDEGIC (1.25mg Per Day) (View Cardegic Review and Cardegic Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), DOLIPRANE (4g Four Times Per Day) (View Doliprane Review and Doliprane Label ), BLOOD CELLS (View Blood Cells Review and Blood Cells Label ). Patient was hospitalized.

6417903-9 | Accidental Overdose, Febrile Neutropenia, Oral Herpes, Rash, Thrombocytopenia
Patient was taking Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: accidental overdose, febrile neutropenia, oral herpes, rash (What is rash?), thrombocytopenia on Oct 22, 2009 from ISRAEL Additional patient health information: Female patient , weighting 174.2 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Melphalan dosage: 14mg Per Day. During the same period patient was treated with PREDNISONE TAB (158mg Per Day) (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6415914-0 | Dehydration, Nausea
Adverse event was reported on Oct 20, 2009 by a Male patient taking Melphalan (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 62 years of age, weighting 192.5 lb, Patient experienced the following unwanted or unexpected effects: dehydration, nausea (What is nausea?). During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), ZOFRAN (View Zofran Review and Zofran Label ), PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ). Patient was hospitalized.

6413911-2 | Chest Discomfort, Deep Vein Thrombosis, Joint Swelling, Oedema Peripheral, Pain In Extremity, Pulmonary Embolism
on Oct 22, 2009 Male patient from BELGIUM , weighting 191.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), hypertension, angina pectoris, prophylaxis, thrombosis prophylaxis and was treated with Melphalan (View Usage). Patient had the following side effects: chest discomfort, deep vein thrombosis (What is deep vein thrombosis?), joint swelling, oedema peripheral, pain in extremity, pulmonary embolism (What is pulmonary embolism?). Melphalan dosage: .25mgk Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (2mgk Per Day) (View Prednisone Review and Prednisone Label ), DILTIAZEM (300mg Per Day) (View Diltiazem Review and Diltiazem Label ), MOLSIDOMINE (16mg Per Day) (View Molsidomine Review and Molsidomine Label ), CACIT D3 (1g Per Day) (View Cacit D3 Review and Cacit D3 Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), PERINDOPRIL TERT BUTYLAMINE (4mg Per Day) (View Perindopril Tert-butylamine Review and Perindopril Tert-butylamine Label ), ACETYLSALICYLIC ACID (100mg Per Day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ). Patient was hospitalized.

6393552-6 | Blister, Blood Calcium Decreased, C-reactive Protein Increased, Erythema, Haemoglobin Decreased, Nausea, Platelet Count Increased, Urinary Tract Infection
on Oct 05, 2009 Male patient from SWEDEN , weighting 148.4 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), osteoporosis (What is osteoporosis?) and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: blister, blood calcium decreased, c-reactive protein increased, erythema, haemoglobin decreased, nausea (What is nausea?), platelet count increased, urinary tract infection (What is urinary tract infection?). Melphalan dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LOSARTAN (View Losartan Review and Losartan Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OXYCODON (View Oxycodon Review and Oxycodon Label ). Patient was hospitalized.

6388465-X | Abdominal Pain
Patient was taking Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?) on Sep 30, 2009 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 219.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Melphalan dosage: 9mgm2 Cyclic. During the same period patient was treated with VELCADE (1.3mgm2 Cyclic) (View Velcade Review and Velcade Label ), PREDNISONE TAB (60mgm2 Cyclic) (View Prednisone Tab Review and Prednisone Tab Label ), ALOXI (View Aloxi Review and Aloxi Label ). Patient was hospitalized.

6367470-3 | Malaise, Pyrexia, Streptococcal Sepsis
Adverse event was reported on Sep 10, 2009 by a Male patient taking Melphalan (View Usage) (Dosage: 10mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: BELGIUM , weighting 127.9 lb, Patient had the following side effects: malaise, pyrexia, streptococcal sepsis. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6360877-X | Pyrexia, Renal Failure
on Sep 15, 2009 Male patient from UNITED STATES , weighting 190.3 lb, was diagnosed with amyloidosis and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: pyrexia, renal failure. Melphalan dosage: 10mg Daily Days 1-7. During the same period patient was treated with DEXAMETHASONE (40 Mg On Days 1-4 And Days 22-25) (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6358062-0 | Abdominal Pain, Nausea, No Therapeutic Response
on Sep 09, 2009 Male patient from UNITED STATES , 62 years of age, weighting 196.0 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), nausea (What is nausea?) and was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?), no therapeutic response. Melphalan dosage: 18mg Per Day. During the same period patient was treated with VELCADE (2.8mg Per Day) (View Velcade Review and Velcade Label ), PREDNISONE (130mg Per Day) (View Prednisone Review and Prednisone Label ), ZOFRAN (View Zofran Review and Zofran Label ), PHENERGAN (View Phenergan Review and Phenergan Label ). Patient was hospitalized.

6297933-0 | Hypovolaemia, Presyncope
Patient was taking Melphalan (View Usage). Patient had the following side effects: hypovolaemia, presyncope on Jul 28, 2009 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 139.6 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Melphalan dosage: 200mgm2 Per Day. During the same period patient was treated with BORTEZOMIB (1mgm2 Per Day) (View Bortezomib Review and Bortezomib Label ). Patient was hospitalized.

6283850-9 | Neutrophil Count Decreased, Pyrexia
Adverse event was reported on Jul 23, 2009 by a Female patient taking Melphalan (View Usage) (Dosage: 340 Mg) . Location: UNITED STATES , weighting 137.1 lb, After Melphalan was administered, patient had the following side effects: neutrophil count decreased, pyrexia. Patient was hospitalized.

6282199-8 | Neutrophil Count Decreased, Pyrexia
on Jul 21, 2009 Female patient from UNITED STATES , weighting 137.1 lb, was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased, pyrexia. Melphalan dosage: 340 Mg. Patient was hospitalized.

6272046-2 | Diarrhoea Haemorrhagic, Gastrointestinal Inflammation, Hypotension, Impaired Healing, Lobar Pneumonia, Neutropenic Sepsis
on Jul 06, 2009 Male patient from UNITED STATES , 47 years of age, was treated with Melphalan (View Usage). Patient had the following side effects: diarrhoea haemorrhagic, gastrointestinal inflammation, hypotension, impaired healing, lobar pneumonia, neutropenic sepsis. Melphalan dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ).

6270356-6 | Gangrene, Haemoglobin Abnormal, Leukopenia, Neutropenia
Patient was taking Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: gangrene, haemoglobin abnormal, leukopenia, neutropenia on Jul 08, 2009 from SPAIN Additional patient health information: Female patient , weighting 238.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), atrial fibrillation (What is atrial fibrillation?), vomiting, pain (What is pain?), prophylaxis and. Melphalan dosage: .25mgk Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE TAB (2mgk Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), ATENOLOL (25mg Per Day) (View Atenolol Review and Atenolol Label ), ONDANSETRON (8mg Twice Per Day) (View Ondansetron Review and Ondansetron Label ), PHENTANYL (25mg Every 3 Days) (View Phentanyl Review and Phentanyl Label ), CALCIUM (500mg Per Day) (View Calcium Review and Calcium Label ), VITAMIN D3 (31unit Per Day) (View Vitamin D3 Review and Vitamin D3 Label ), ENOXAPARIN SODIUM (80mg Per Day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6269002-7 | Hypoxia, Pyrexia
Adverse event was reported on Jul 10, 2009 by a Male patient taking Melphalan (View Usage) (Dosage: 9mgm2 Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: UNITED STATES , 81 years of age, weighting 193.3 lb, Patient experienced the following unwanted or unexpected effects: hypoxia, pyrexia. During the same period patient was treated with BORTEZOMIB (2.7mgm2 Per Day) (View Bortezomib Review and Bortezomib Label ), PREDNISONE TAB (60mgm2 Per Day) (View Prednisone Tab Review and Prednisone Tab Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), K DUR (View K-dur Review and K-dur Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ). Patient was hospitalized.

6265265-2 | Neutrophil Count Decreased, Pyrexia
on Jul 09, 2009 Female patient from UNITED STATES , weighting 137.1 lb, was treated with Melphalan (View Usage). Patient had the following side effects: neutrophil count decreased, pyrexia. Melphalan dosage: 340 Mg. Patient was hospitalized.

6258749-4 | Dyspnoea, Multi-organ Failure, Neutropenia, Pneumonia, Pyrexia, Respiratory Failure
on Jul 03, 2009 Female patient from SPAIN , weighting 137.8 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: dyspnoea, multi-organ failure, neutropenia, pneumonia (What is pneumonia?), pyrexia, respiratory failure. Melphalan dosage: 12mg Cyclic. During the same period patient was treated with LENALIDOMIDE (7.5mg Cyclic) (View Lenalidomide Review and Lenalidomide Label ), PREDNISONE (130mg Cyclic) (View Prednisone Review and Prednisone Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ). Patient was hospitalized.

6258740-8 | Cholecystitis, Gangrene, Haemoglobin Abnormal, Leukopenia, Neutropenia, Platelet Count Decreased, Red Blood Cell Count Decreased
Patient was taking Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis, gangrene, haemoglobin abnormal, leukopenia, neutropenia, platelet count decreased, red blood cell count decreased on Jul 02, 2009 from SPAIN Additional patient health information: Female patient , weighting 238.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?), atrial fibrillation (What is atrial fibrillation?), vomiting, pain (What is pain?), prophylaxis and. Melphalan dosage: .25mgk Per Day. During the same period patient was treated with THALIDOMIDE (200mg Per Day) (View Thalidomide Review and Thalidomide Label ), PREDNISONE (2mgk Per Day) (View Prednisone Review and Prednisone Label ), ATENOLOL (25mg Per Day) (View Atenolol Review and Atenolol Label ), ONDANSETRON (8mg Twice Per Day) (View Ondansetron Review and Ondansetron Label ), PHENTANYL (25mg Every 3 Days) (View Phentanyl Review and Phentanyl Label ), CALCIUM (500mg Per Day) (View Calcium Review and Calcium Label ), VITAMIN D3 (31unit Per Day) (View Vitamin D3 Review and Vitamin D3 Label ), ENOXAPARIN SODIUM (80mg Per Day) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

6249487-2 | Anaemia, Blood Creatinine Increased, Chills, Cough, Fatigue, Hypercalcaemia, Lung Infiltration, Neutropenia
Adverse event was reported on Jun 19, 2009 by a Female patient taking Melphalan (View Usage) (Dosage: 14mg Per Day) was diagnosed with multiple myeloma (What is multiple myeloma?), peripheral arterial occlusive disease, prophylaxis and. Location: AUSTRIA , weighting 158.7 lb, Patient had the following side effects: anaemia, blood creatinine increased, chills, cough, fatigue, hypercalcaemia, lung infiltration, neutropenia. During the same period patient was treated with PREDNISOLONE (69mg Per Day) (View Prednisolone Review and Prednisolone Label ), MAXI KALZ (View Maxi Kalz Review and Maxi Kalz Label ), PANTALOC (40mg Per Day) (View Pantaloc Review and Pantaloc Label ), RESOCHIN (View Resochin Review and Resochin Label ), ATARAX (25mg Per Day) (View Atarax Review and Atarax Label ), ZADITEN (View Zaditen Review and Zaditen Label ), OLEOVIT (View Oleovit Review and Oleovit Label ). Patient was hospitalized.

6222613-7 | Cardiac Failure Congestive, Clostridial Infection, Encephalopathy, Failure To Thrive, Fall, Hypotension, Mucosal Inflammation, Neutropenia, Pleural Effusion
on Jun 09, 2009 Female patient from UNITED STATES , weighting 134.7 lb, was treated with Melphalan (View Usage). After Melphalan was administered, patient had the following side effects: cardiac failure congestive, clostridial infection, encephalopathy, failure to thrive, fall (What is fall?), hypotension, mucosal inflammation, neutropenia, pleural effusion. Melphalan dosage: 162 Mg. During the same period patient was treated with G CSF (FILGRASTIM, AMGEN) (289 Mcg) (View G-csf (filgrastim, Amgen) Review and G-csf (filgrastim, Amgen) Label ). Patient was hospitalized.

6222605-8 | Clostridial Infection, Diarrhoea, Encephalopathy, Failure To Thrive, Fall, Hypotension, Mucosal Inflammation, Neutropenia, Platelet Count Decreased
on Jun 09, 2009 Female patient from UNITED STATES , weighting 134.7 lb, was treated with Melphalan (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, diarrhoea, encephalopathy, failure to thrive, fall (What is fall?), hypotension, mucosal inflammation, neutropenia, platelet count decreased. Melphalan dosage: 162 Mg. During the same period patient was treated with G CSF (FILGRASTIM, AMGEN) (289 Mcg) (View G-csf (filgrastim, Amgen) Review and G-csf (filgrastim, Amgen) Label ). Patient was hospitalized.

6222602-2 | Bacteria Stool Identified, Diarrhoea, Encephalopathy, Failure To Thrive, Mucosal Inflammation, Neutropenia, Pyrexia
Patient was taking Melphalan (View Usage). Patient had the following side effects: bacteria stool identified, diarrhoea, encephalopathy, failure to thrive, mucosal inflammation, neutropenia, pyrexia on Jun 09, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.7 lb, . Melphalan dosage: 162 Mg. During the same period patient was treated with G CSF (FILGRASTIM, AMGEN) (289 Mcg) (View G-csf (filgrastim, Amgen) Review and G-csf (filgrastim, Amgen) Label ).